Terumo Blood and Cell Technologies (BCT), a global leader in blood and cellular technologies, partnered with FCM to improve their travel management. Facing challenges with program leakage and fragmented traveler behavior, Terumo sought to engage travelers positively to ensure compliance and cost savings. The partnership with FCM provided customized solutions, including mobile app adoption, enhanced traveler engagement, and hotel program savings. During the COVID-19 pandemic, FCM helped Terumo manage unused tickets, secure cost savings, and provide essential travel information, ensuring continued support and efficiency in challenging times.

Join for free to read